drugset / Trial / NCT02704091

Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults

NCT02704091

Phase 4 Completed 858 enrolled Ipsen
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to demonstrate that diosmectite efficacy is superior to placebo regarding time to recovery of an acute diarrhoea episode presumed of infectious origin in adult subjects.

Timeline

Start
2016-03-17
Primary completion
2019-04-08
Completion
2019-04-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator montmorillonite Other / unclassified

Indications